Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
PUT
National Beverage
FIZZ
$2.93B
| $6.4M | ﹤0.01% |
131,400
+71,800
| +120% | +$3.68M |
|
2052
PUT
British American Tobacco
BTI
$123B
| $6.4M | ﹤0.01% |
95,500
+44,700
| +88% | +$2.91M |
|
2053
CALL
Dominion Energy
D
$60.5B
| $6.4M | ﹤0.01% |
78,900
+32,500
| +70% | +$2.63M |
|
|
CBAY
2054
DELISTED
Cymabay Therapeutics
CBAY
| $6.39M | ﹤0.01% |
694,252
+54,225
| +8% | +$463K |
|
2055
PUT
Clorox
CLX
$12.8B
| $6.38M | ﹤0.01% |
42,900
-7,000
| -14% | -$952K |
|
2056
PUT
Williams-Sonoma
WSM
$28.4B
| $6.38M | ﹤0.01% |
246,600
-38,400
| -13% | -$979K |
|
|
AMAG
2057
DELISTED
AMAG Pharmaceuticals
AMAG
| $6.38M | ﹤0.01% |
+481,129
| New | +$7.25M |
|
2058
CALL
Darden Restaurants
DRI
$25.6B
| $6.37M | ﹤0.01% |
66,300
-2,600
| -4% | -$220K |
|
2059
Westlake Corp
WLK
$10.2B
| $6.36M | ﹤0.01% |
59,734
-835,154
| -93% | -$77.4M |
|
2060
Selective Insurance
SIGI
$5.62B
| $6.35M | ﹤0.01% |
108,181
+62,777
| +138% | +$3.63M |
|
2061
PUT
TAL Education Group
TAL
$6.46B
| $6.35M | ﹤0.01% |
213,700
-137,300
| -39% | -$4.18M |
|
2062
PUT
TotalEnergies
TTE
$196B
| $6.33M | ﹤0.01% |
10,491,063
+2,373,845
| +29% | +$1.42M |
|
2063
PUT
Diamondback Energy
FANG
$56.7B
| $6.33M | ﹤0.01% |
50,100
+5,700
| +13% | +$618K |
|
2064
PUT
Zimmer Biomet
ZBH
$19.2B
| $6.32M | ﹤0.01% |
53,972
+15,038
| +39% | +$1.7M |
|
|
FRAN
2065
DELISTED
Francesca's Holdings Corporation
FRAN
| $6.31M | ﹤0.01% |
71,946
+54,716
| +318% | +$4.6M |
|
2066
Maximus
MMS
$2.89B
| $6.31M | ﹤0.01% |
88,136
-43,432
| -33% | -$2.92M |
|
2067
CALL
GSK
GSK
$99.2B
| $6.31M | ﹤0.01% |
142,240
+43,280
| +44% | +$2M |
|
2068
Strategy Inc
MSTR
$36.6B
| $6.3M | ﹤0.01% |
480,120
-84,470
| -15% | -$1.13M |
|
|
2069
CALL
Clorox
CLX
$12.8B
| $6.29M | ﹤0.01% |
42,300
+17,900
| +73% | +$2.44M |
|
2070
PUT
Tyson Foods
TSN
$20.5B
| $6.29M | ﹤0.01% |
77,600
-11,600
| -13% | -$888K |
|
2071
Outfront Media
OUT
$5.33B
| $6.29M | ﹤0.01% |
275,494
-85,412
| -24% | -$2M |
|
2072
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.88B
| $6.29M | ﹤0.01% |
197,394
+44,212
| +29% | +$1.44M |
|
2073
iShares Core S&P US Value ETF
IUSV
$28B
| $6.29M | ﹤0.01% |
+113,424
| New | +$6.1M |
|
2074
PUT
Cigna
CI
$74.7B
| $6.28M | ﹤0.01% |
30,900
+6,200
| +25% | +$1.23M |
|
2075
iShares MSCI Kokusai Fund
TOK
$258M
| $6.27M | ﹤0.01% |
96,976
+86,545
| +830% | +$5.54M |
|
Similar funds
Citadel Advisors's Q4 2017 Portfolio in Review
As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Citadel Advisors opened 1,440 new positions and closed 988 in Q4 2017.
- Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.